{{Rsnum
|rsid=35804026
|Gene=TRPM6
|Chromosome=9
|position=74737424
|Orientation=plus
|GMAF=0.006887
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TRPM6
}}{{Venter SNP
|rsid=35804026
|allele=C
|frequency=
|uid=1103652098200
|type=heterozygous_SNP
|hugo=TRPM6
|ensembl gene=ENSG00000119121
|ensembl transcript=ENST00000376864
|sift=
|disease=Defects in TRPM6 are the cause of hypomagnesemia with secondary hypocalcemia (HOMG) (MIM:602014); also known as HSH. HOMG is an autosomal recessive disease characterized by low levels of serum magnesium alongside with a normal renal magnesium secretion, secondary hypocalcemia and calcinocis. Affected individuals show neurologic symptoms of hypomagnesemic hypocalcemia, including seizures and muscle spasms, during infancy. Hypocalcemia is secondary to parathyroid failure resulting from magnesium deficiency. Untreated, the disorder may be fatal or may result in neurological damage. Restoring the concentrations of serum magnesium to normal values by high-dose magnesium supplementation can overcome the apparent defect in magnesium absorption and in serum concentrations of calcium.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}